Sapiens Deferred Long Term Liab vs Capital Surpluse Analysis

SPNS Stock

USD 30.31 0.35 1.14%

Sapiens International financial indicator trend analysis is much more than just breaking down Sapiens International prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sapiens International is a good investment. Please check the relationship between Sapiens International Deferred Long Term Liab and its Capital Surpluse accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sapiens International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Sapiens Stock please use our How to Invest in Sapiens International guide.

Deferred Long Term Liab vs Capital Surpluse

Deferred Long Term Liab vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sapiens International Deferred Long Term Liab account and Capital Surpluse. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Sapiens International's Deferred Long Term Liab and Capital Surpluse is -0.64. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Sapiens International, assuming nothing else is changed. The correlation between historical values of Sapiens International's Deferred Long Term Liab and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Sapiens International are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Deferred Long Term Liab i.e., Sapiens International's Deferred Long Term Liab and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

-0.64

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Capital Surpluse

Most indicators from Sapiens International's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sapiens International current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sapiens International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Sapiens Stock please use our How to Invest in Sapiens International guide.At this time, Sapiens International's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 1.6 B in 2024, whereas Selling General Administrative is likely to drop slightly above 38.1 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	187.8M	200.2M	225.4M	236.6M
Total Revenue	461.0M	474.7M	514.6M	540.3M

Gross Profit Total Revenue

Sapiens International fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Common Stock Shares Outstanding		0.5	0.51	0.48	0.43	0.49	0.41	-0.17	0.34	0.58	0.53	0.54	-0.36	0.41	0.52	0.5	-0.72	0.02	0.54	0.28	0.83	0.46	0.28	0.42	0.35	0.71
Total Assets	0.5		0.8	0.99	0.99	0.97	0.84	-0.08	0.93	0.44	0.95	0.99	-0.28	0.97	0.97	0.99	-0.39	0.71	0.79	0.92	0.72	0.96	0.91	0.98	0.87	0.77
Short Long Term Debt Total	0.51	0.8		0.8	0.81	0.65	0.9	0.37	0.65	0.39	0.78	0.86	-0.28	0.7	0.77	0.81	-0.16	0.31	0.99	0.61	0.62	0.93	0.74	0.7	0.88	0.92
Other Current Liab	0.48	0.99	0.8		0.99	0.95	0.85	-0.01	0.95	0.46	0.91	0.98	-0.3	0.94	0.98	0.98	-0.35	0.73	0.79	0.91	0.67	0.96	0.92	0.96	0.87	0.75
Total Current Liabilities	0.43	0.99	0.81	0.99		0.95	0.85	-0.03	0.95	0.42	0.92	0.98	-0.28	0.96	0.97	0.98	-0.3	0.74	0.79	0.92	0.66	0.96	0.93	0.97	0.91	0.74
Total Stockholder Equity	0.49	0.97	0.65	0.95	0.95		0.73	-0.28	0.93	0.43	0.93	0.94	-0.26	0.98	0.94	0.95	-0.46	0.75	0.64	0.93	0.75	0.86	0.87	0.99	0.79	0.66
Property Plant And Equipment Net	0.41	0.84	0.9	0.85	0.85	0.73		0.28	0.72	0.26	0.78	0.87	-0.25	0.78	0.76	0.81	-0.19	0.48	0.86	0.71	0.57	0.9	0.9	0.76	0.89	0.74
Net Debt	-0.17	-0.08	0.37	-0.01	-0.03	-0.28	0.28		-0.13	-0.22	-0.26	0.03	0.04	-0.26	-0.1	-0.02	0.3	-0.11	0.38	-0.1	-0.34	0.17	0.1	-0.23	0.11	0.23
Retained Earnings	0.34	0.93	0.65	0.95	0.95	0.93	0.72	-0.13		0.43	0.84	0.88	-0.36	0.94	0.94	0.91	-0.19	0.85	0.63	0.91	0.54	0.86	0.89	0.96	0.83	0.55
Accounts Payable	0.58	0.44	0.39	0.46	0.42	0.43	0.26	-0.22	0.43		0.5	0.43	-0.41	0.41	0.57	0.47	-0.33	0.12	0.42	0.25	0.52	0.42	0.22	0.45	0.34	0.49
Cash	0.53	0.95	0.78	0.91	0.92	0.93	0.78	-0.26	0.84	0.5		0.92	-0.32	0.95	0.92	0.92	-0.36	0.53	0.76	0.8	0.79	0.89	0.79	0.94	0.85	0.76
Non Current Assets Total	0.54	0.99	0.86	0.98	0.98	0.94	0.87	0.03	0.88	0.43	0.92		-0.26	0.92	0.95	0.99	-0.43	0.63	0.85	0.89	0.73	0.98	0.89	0.94	0.87	0.84
Non Currrent Assets Other	-0.36	-0.28	-0.28	-0.3	-0.28	-0.26	-0.25	0.04	-0.36	-0.41	-0.32	-0.26		-0.3	-0.36	-0.25	-0.06	-0.2	-0.29	-0.18	-0.14	-0.29	-0.24	-0.31	-0.25	-0.2
Cash And Short Term Investments	0.41	0.97	0.7	0.94	0.96	0.98	0.78	-0.26	0.94	0.41	0.95	0.92	-0.3		0.93	0.93	-0.3	0.75	0.67	0.92	0.7	0.88	0.89	0.99	0.85	0.64
Net Receivables	0.52	0.97	0.77	0.98	0.97	0.94	0.76	-0.1	0.94	0.57	0.92	0.95	-0.36	0.93		0.97	-0.34	0.68	0.77	0.86	0.68	0.93	0.83	0.96	0.84	0.75
Good Will	0.5	0.99	0.81	0.98	0.98	0.95	0.81	-0.02	0.91	0.47	0.92	0.99	-0.25	0.93	0.97		-0.42	0.68	0.81	0.91	0.71	0.96	0.88	0.95	0.85	0.81
Common Stock Total Equity	-0.72	-0.39	-0.16	-0.35	-0.3	-0.46	-0.19	0.3	-0.19	-0.33	-0.36	-0.43	-0.06	-0.3	-0.34	-0.42		-0.08	-0.19	-0.32	-0.65	-0.26	-0.21	-0.32	-0.04	-0.46
Short Term Investments	0.02	0.71	0.31	0.73	0.74	0.75	0.48	-0.11	0.85	0.12	0.53	0.63	-0.2	0.75	0.68	0.68	-0.08		0.29	0.88	0.25	0.59	0.79	0.77	0.58	0.22
Non Current Liabilities Total	0.54	0.79	0.99	0.79	0.79	0.64	0.86	0.38	0.63	0.42	0.76	0.85	-0.29	0.67	0.77	0.81	-0.19	0.29		0.59	0.61	0.92	0.7	0.68	0.83	0.94
Other Current Assets	0.28	0.92	0.61	0.91	0.92	0.93	0.71	-0.1	0.91	0.25	0.8	0.89	-0.18	0.92	0.86	0.91	-0.32	0.88	0.59		0.58	0.83	0.91	0.93	0.76	0.58
Other Stockholder Equity	0.83	0.72	0.62	0.67	0.66	0.75	0.57	-0.34	0.54	0.52	0.79	0.73	-0.14	0.7	0.68	0.71	-0.65	0.25	0.61	0.58		0.64	0.53	0.69	0.63	0.76
Total Liab	0.46	0.96	0.93	0.96	0.96	0.86	0.9	0.17	0.86	0.42	0.89	0.98	-0.29	0.88	0.93	0.96	-0.26	0.59	0.92	0.83	0.64		0.89	0.9	0.91	0.86
Property Plant And Equipment Gross	0.28	0.91	0.74	0.92	0.93	0.87	0.9	0.1	0.89	0.22	0.79	0.89	-0.24	0.89	0.83	0.88	-0.21	0.79	0.7	0.91	0.53	0.89		0.89	0.86	0.6
Total Current Assets	0.42	0.98	0.7	0.96	0.97	0.99	0.76	-0.23	0.96	0.45	0.94	0.94	-0.31	0.99	0.96	0.95	-0.32	0.77	0.68	0.93	0.69	0.9	0.89		0.85	0.65
Short Term Debt	0.35	0.87	0.88	0.87	0.91	0.79	0.89	0.11	0.83	0.34	0.85	0.87	-0.25	0.85	0.84	0.85	-0.04	0.58	0.83	0.76	0.63	0.91	0.86	0.85		0.72
Intangible Assets	0.71	0.77	0.92	0.75	0.74	0.66	0.74	0.23	0.55	0.49	0.76	0.84	-0.2	0.64	0.75	0.81	-0.46	0.22	0.94	0.58	0.76	0.86	0.6	0.65	0.72

Click cells to compare fundamentals

Sapiens International Account Relationship Matchups

Sapiens International fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	50.7M	52.2M	55.6M	55.6M	55.7M	28.3M
Total Assets	452.4M	714.2M	715.0M	666.8M	689.6M	724.1M
Short Long Term Debt Total	120.5M	177.2M	148.4M	116.6M	87.0M	46.8M
Other Current Liab	60.6M	75.1M	76.5M	77.0M	77.9M	81.8M
Total Current Liabilities	104.9M	144.8M	151.7M	146.0M	149.1M	156.6M
Total Stockholder Equity	225.5M	383.7M	408.7M	402.9M	447.3M	469.6M
Property Plant And Equipment Net	66.1M	71.4M	58.1M	45.7M	36.2M	38.0M
Net Debt	54.2M	24.6M	(41.9M)	(43.7M)	(39.7M)	(37.7M)
Retained Earnings	17.9M	44.6M	71.6M	85.6M	119.9M	125.9M
Accounts Payable	5.1M	5.4M	5.0M	9.4M	6.3M	4.5M
Cash	66.3M	152.6M	190.2M	160.3M	126.7M	133.1M
Non Current Assets Total	305.2M	446.8M	414.6M	381.4M	374.7M	393.5M
Non Currrent Assets Other	5.3M	5.3M	7.3M	4.8M	6.1M	10.9M
Cash And Short Term Investments	89.2M	182.6M	210.2M	180.3M	202.1M	212.2M
Net Receivables	58.0M	84.8M	90.1M	105.0M	90.3M	94.8M
Good Will	170.7M	264.3M	261.1M	252.2M	256.3M	269.1M
Liabilities And Stockholders Equity	452.4M	714.2M	715.0M	666.8M	689.6M	724.1M
Non Current Liabilities Total	122.0M	185.7M	154.6M	117.9M	90.6M	45.7M
Other Current Assets	7.8M	19.4M	13.8M	11.6M	22.5M	23.6M
Other Stockholder Equity	209.3M	327.3M	333.6M	337.7M	343.9M	183.9M
Total Liab	226.9M	330.5M	306.3M	263.9M	239.7M	251.7M
Property Plant And Equipment Gross	66.1M	71.4M	58.1M	45.7M	74.3M	78.0M
Total Current Assets	147.2M	267.4M	300.3M	285.3M	314.9M	330.6M
Accumulated Other Comprehensive Income	(2.4M)	11.0M	2.8M	(21.1M)	(17.3M)	(16.4M)
Short Term Debt	18.2M	29.7M	30.6M	28.9M	26.4M	15.6M
Intangible Assets	58.0M	99.3M	82.1M	67.4M	61.0M	31.9M
Common Stock	695K	697K	751K	756K	762K	723.9K
Other Liab	19.8M	37.7M	36.7M	31.7M	36.5M	38.3M
Current Deferred Revenue	21.0M	34.5M	39.6M	30.7M	38.5M	40.5M
Other Assets	10.4M	11.8M	13.2M	17.7M	15.9M	8.6M
Long Term Debt	58.9M	98.7M	79.0M	59.3M	39.5M	35.4M
Property Plant Equipment	66.1M	71.4M	58.1M	45.7M	52.6M	55.2M
Net Tangible Assets	(4.9M)	18.1M	65.4M	80.8M	72.8M	76.4M
Non Current Liabilities Other	8.3M	12.1M	12.1M	11.7M	11.5M	11.5M
Net Invested Capital	292.6M	500.2M	98.8M	79.1M	506.6M	319.8M

Currently Active Assets on Macroaxis

MSFT	Microsoft
CRM	Salesforce
GOOG	Alphabet Inc Class C
V	Visa Class A
F	Ford Motor

When determining whether Sapiens International is a strong investment it is important to analyze Sapiens International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sapiens International's future performance. For an informed investment choice regarding Sapiens Stock, refer to the following important reports:

How To Invest In Sapiens

Details

Is Sapiens Stock a good investment?

Details

What is Sapiens International's Net Worth?

Details

Largest Application Software Companies

View

Largest Software - Application Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sapiens International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Sapiens Stock please use our How to Invest in Sapiens International guide.

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Sapiens Stock analysis

When running Sapiens International's price analysis, check to measure Sapiens International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sapiens International is operating at the current time. Most of Sapiens International's value examination focuses on studying past and present price action to predict the probability of Sapiens International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sapiens International's price. Additionally, you may evaluate how the addition of Sapiens International to your portfolios can decrease your overall portfolio volatility.

	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	CEOs Directory Screen CEOs from public companies around the world
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios

Is Sapiens International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sapiens International. If investors know Sapiens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sapiens International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.25

Dividend Share

0.54

Earnings Share

1.12

Revenue Per Share

9.293

Quarterly Revenue Growth

0.095

The market value of Sapiens International is measured differently than its book value, which is the value of Sapiens that is recorded on the company's balance sheet. Investors also form their own opinion of Sapiens International's value that differs from its market value or its book value, called intrinsic value, which is Sapiens International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sapiens International's market value can be influenced by many factors that don't directly affect Sapiens International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sapiens International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sapiens International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sapiens International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sapiens Deferred Long Term Liab vs Capital Surpluse Analysis

Deferred Long Term Liab vs Capital Surpluse

Deferred Long Term Liab vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Capital Surpluse

Sapiens International fundamental ratios Correlations

Sapiens International Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sapiens International fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Sapiens Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Current Liab	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Good Will	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Current Liabilities	+ 0.99	Other Current Liab

Common Stock Total Equity	- 0.72	Common Stock Shares Outstanding
Other Stockholder Equity	- 0.65	Common Stock Total Equity
Intangible Assets	- 0.46	Common Stock Total Equity
Common Stock Total Equity	- 0.46	Total Stockholder Equity
Common Stock Total Equity	- 0.43	Non Current Assets Total
Common Stock Total Equity	- 0.42	Good Will